Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in Eur Neurol

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BURGGRAAFF J, Knol DL, Uitdehaag BM
    Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available


    December 2016
  2. MOREAU T, Bungener C, Heinzlef O, Suchet L, et al
    Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.
    Eur Neurol. 2016;77.
    PubMed     Text format     Abstract available


    October 2016
  3. VERMERSCH P, Trojano M
    Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available


  4. VILLAR-QUILES RN, Matias-Guiu JA, Ortega G, Gonzalez-Suarez I, et al
    Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available


    August 2016
  5. NOVOTNA K, Sobisek L, Horakova D, Havrdova E, et al
    Quantification of Gait Abnormalities in Healthy-Looking Multiple Sclerosis Patients (with Expanded Disability Status Scale 0-1.5).
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available


    July 2016
  6. CARDAIOLI G, Di Filippo M, Bianchi A, Eusebi P, et al
    Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available


  7. MECA-LALLANA J, Hernandez L, Caminero AB, Giron JM, et al
    Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-beta to Glatiramer Acetate in Clinical Practice.
    Eur Neurol. 2016;76.
    PubMed     Text format     Abstract available


    June 2016
  8. SCHIMRIGK S, Faiss J, Kohler W, Gunther A, et al
    Escalation Therapy of Steroid Refractory Multiple Sclerosis Relapse with Tryptophan Immunoadsorption - Observational Multicenter Study with 147 Patients.
    Eur Neurol. 2016;75.
    PubMed     Text format     Abstract available


  9. RIBES GARCIA S, Gomez-Pajares F, Albelda Puig C, Garcia Herrera JL, et al
    Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
    Eur Neurol. 2016;75.
    PubMed     Text format     Abstract available


    May 2016
  10. HAUPTS M, Vila C, Jonas A, Witte K, et al
    Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
    Eur Neurol. 2016;75.
    PubMed     Text format     Abstract available


    April 2016
  11. TANAKA M, Nakahara K, Kinoshita M
    Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
    Eur Neurol. 2016;75.
    PubMed     Text format     Abstract available


    January 2016
  12. GIANTZI V, Karapanayiotides T, Lagoudaki R, Poulatsidou KN, et al
    The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
    Eur Neurol. 2016;75.
    PubMed     Text format     Abstract available


  13. PATTI F
    Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
    Eur Neurol. 2016;75 Suppl 1:9-12.
    PubMed     Text format     Abstract available


  14. TROJANO M
    THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
    Eur Neurol. 2016;75 Suppl 1:4-8.
    PubMed     Text format     Abstract available


  15. FERNANDEZ O
    THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
    Eur Neurol. 2016;75 Suppl 1:1-3.
    PubMed     Text format     Abstract available


    December 2015
  16. ALTINTAS A, Najar B, Gozubatik-Celik G, Menku SF, et al
    Pregnancy Data in a Turkish Multiple Sclerosis Population.
    Eur Neurol. 2015;74.
    PubMed     Text format     Abstract available


  17. MAGNIN E, Sagawa Y Jr, Chamard L, Berger E, et al
    Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
    Eur Neurol. 2015;74.
    PubMed     Text format     Abstract available


    November 2015
  18. TROJANO M, Vila C
    Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.
    Eur Neurol. 2015;74.
    PubMed     Text format     Abstract available


    April 2015
  19. POMPA A, Clemenzi A, Troisi E, Pace L, et al
    Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
    Eur Neurol. 2015;73.
    PubMed     Text format     Abstract available


    March 2015
  20. VON BUDINGEN HC, Palanichamy A, Lehmann-Horn K, Michel BA, et al
    Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets.
    Eur Neurol. 2015;73.
    PubMed     Text format     Abstract available


  21. KOUDRIAVTSEVA T, Renna R, Plantone D, Mandoj C, et al
    Association between Anemia and Multiple Sclerosis.
    Eur Neurol. 2015;73.
    PubMed     Text format     Abstract available


  22. COBO-CALVO A, Bau L, Matas E, Romero-Pinel L, et al
    Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
    Eur Neurol. 2015;73.
    PubMed     Text format     Abstract available


    November 2014
  23. BIANCO A, Patanella AK, Nociti V, Marti A, et al
    Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
    Eur Neurol. 2014;73.
    PubMed     Text format     Abstract available


    January 2014
  24. DOERNER M, Beckmann K, Knappertz V, Kappos L, et al
    Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study.
    Eur Neurol. 2014;71.
    PubMed     Text format     Abstract available


  25. WANG P, Xie K, Wang C, Bi J, et al
    Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Eur Neurol. 2014;72.
    PubMed     Text format     Abstract available


  26. FLACHENECKER P, Henze T, Zettl UK
    Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.
    Eur Neurol. 2014;72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: